2011•Medical Journal of Chinese People's HealthRequires access

Quetiapine and Risperidone treatment of chronic schizophrenia comparative study

Yuewei Li

Abstract

Objective:To compare the efficacy and safety between Quetiapine and Risperidone in the treatment of chronic schizophrenia.Methods:Seventy patients with chronic schizophrenia were randomly divided into two groups receiving Quetiapine or Risperidone treatment respectively.The period of treatment were 8 weeks.The positive and negative symptom scale(PANSS) and treatment emergent symptom scale(TESS) were used to evaluate the efficacy and side effects.Results:Both groups had similar efficacy and severity of side effects.Conclusion:Both Quetiapine and Risperidone have definite effect and rather high safety in the treatment of chronic schizophrenia.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Risperidone, Quetiapine, Schizophrenia (object-oriented programming), Negative symptom, Medicine, Psychiatry, Internal medicine, Positive and Negative Syndrome Scale